PMID- 19794906 OWN - NLM STAT- MEDLINE DCOM- 20110128 LR - 20220410 IS - 1942-0994 (Electronic) IS - 1942-0900 (Print) IS - 1942-0994 (Linking) VI - 1 IP - 1 DP - 2008 Oct-Dec TI - Primary mouse renal tubular epithelial cells have variable injury tolerance to ischemic and chemical mediators of oxidative stress. PG - 33-8 AB - We have developed and evaluated an in vitro culture method for assessing ischemic injury in primary mouse renal tubular epithelial cells (RTEC) in which to explore the pathobiology underlying acute kidney injury. RTEC were predominately of proximal tubule origin which is most susceptible to ischemic injury as compared to other nephron segments. Oxidative stress was induced by chemically depleting ATP using Antimycin A and 2-Deoxy-D-Glucose and by exposing cells to a 1% oxygen environment. Necrotic injury was assessed by measuring LDH released into culture supernatants. Optimal dose and time of exposure to each injury agent was determined for induction of mild, moderate and severe ischemic injury defined as LDH release of /= 50% above baseline respectively. Antimycin A and 2-Deoxy-D-Glucose produced a progressive increase in LDH release which was time dependent but chemical concentration independent. A 1% oxygen environment also induced cell injury over time but only if glucose was absent from the culture media. Antimycin A was most effective at inducing oxidative stress causing a mean LDH release of 61% at 48 hr compared to 19% and 50% LDH release induced by 2-Deoxy-D-Glucose and by exposure to 1% oxygen respectively at the same 48 hour time point.The cell culture method described provides several advantages including the use of serum free media and the ability to grow primary cells without matrix support. The LDH assay for injury assessment is reproducible, cost effective, objective and minimizes background cell death. A simple method for the culture and injury of primary mouse renal tubular epithelial cells has thereby been established and provides a useful tool for future investigations of ischemic kidney injury. FAU - Breggia, Anne C AU - Breggia AC AD - Maine Medical Center Research Institute, Clinical and Translational Research, Portland, Maine 04102, USA. FAU - Himmelfarb, Jonathan AU - Himmelfarb J LA - eng PT - Journal Article PL - United States TA - Oxid Med Cell Longev JT - Oxidative medicine and cellular longevity JID - 101479826 RN - 642-15-9 (Antimycin A) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - 9G2MP84A8W (Deoxyglucose) RN - EC 1.1.1.27 (L-Lactate Dehydrogenase) SB - IM MH - Acute Kidney Injury/metabolism/*pathology MH - Adenosine Triphosphate/deficiency/metabolism MH - Animals MH - Antimycin A/pharmacology MH - Cell Death/physiology MH - Cell Hypoxia/physiology MH - Cells, Cultured MH - Deoxyglucose/pharmacology MH - Epithelial Cells/metabolism/pathology MH - Ischemia/metabolism/pathology MH - Kidney Tubules, Proximal/blood supply/*metabolism/*pathology MH - L-Lactate Dehydrogenase/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Oxidative Stress/physiology PMC - PMC2715195 OTO - NOTNLM OT - ATP OT - acute kidney injury OT - glycolysis OT - ischemia OT - lactate dehydrogenase OT - necrosis OT - renal tubular epithelial cells EDAT- 2009/10/02 06:00 MHDA- 2011/02/01 06:00 CRDT- 2009/10/02 06:00 PHST- 2008/05/14 00:00 [received] PHST- 2008/06/19 00:00 [revised] PHST- 2008/06/23 00:00 [accepted] PHST- 2009/10/02 06:00 [entrez] PHST- 2009/10/02 06:00 [pubmed] PHST- 2011/02/01 06:00 [medline] AID - 1942-0900-1-1-4 [pii] AID - 10.4161/oxim.1.1.6491 [doi] PST - ppublish SO - Oxid Med Cell Longev. 2008 Oct-Dec;1(1):33-8. doi: 10.4161/oxim.1.1.6491.